3D Printing for Healthcare: R&D, Industry and Market 2014-2024

医療用3Dプリンター市場(2014-2024)

◆タイトル:3D Printing for Healthcare: R&D, Industry and Market 2014-2024
◆商品コード:Visiongain-4052611
◆調査・発行会社:visiongain
◆発行日:2014年1月
◆ページ数:162
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single user licence(1名使用)GBP1,799 ⇒換算¥266,252見積依頼/購入/質問フォーム
Dept Licence(部署内共有可)GBP2,999 ⇒換算¥443,852見積依頼/購入/質問フォーム
Site Licence(同一国内社内共有可)GBP4,999 ⇒換算¥739,852見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"医療用3Dプリンター市場(2014-2024)"について調査・分析し、エグゼクティブサマリー、市場動向、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、研究開発パイプライン分析、専門家の見解、結論などの情報をお届けいたします。

Printing in three dimensions for medicine – this new analysis explains trends, technologies, and sales potentials
What’s the future of additive manufacturing for medicine? That’s fabricating three dimensional solid objects from digital models, via 3D printers. Visiongain’s new report gives data you need there, letting you explore developments, technology, and revenue predictions.
That analysis forecasts revenues there to 2024 at overall world market, submarket, and national level. Avoid falling behind in knowledge, missing business or losing influence.
Explore, then, the commercial prospects of those computer controlled industrial robots for performing additive processes. See outlooks for medical devices, tissues, drugs and more.
Advances in manufacturing for medicine – find what that printer technology could be worth
So find potentials for those novel production tools for creating shapes and patterns – multiform designs. You explore that medical business. Now discover how you could gain.
Read on, then, to explore those products and applications, seeing what the future market could be worth.
Forecasts to 2024 and other information to help you stay ahead in knowledge
Besides revenue forecasting to 2024, our new work shows you historical data, recent results, growth rates, and market shares. There you explore research and development (R&D) too. You also get 50 tables, 50 charts, and three interviews with people in that field.
Information to help your work and save time, benefiting your authority
Is finding data on novel prototyping and production systems for health a challenge? Now make your work easier. And save time. That way you can stay ahead in knowledge, helping your research, analyses, and decisions. Also benefit your influence.
Our study lets you investigate the most promising and lucrative aspects of that producing. There you assess methods, equipment, and their uses, hearing what’s going on and seeing where money lies. Try our new report, then, gaining feel for the 3D printing sector’s potential.
And the following sections outline what you get in that new investigation.
Forecasting of that world market and its main segments – what’s likely to happen?
What’re the secrets of that industry’s progress? What’s the potential of that chemistry and engineering for medicine? Discover in our report overall world revenue to 2024 for those synthetic processes for medical applications.
Also find individual revenue predictions to 2024 for six submarkets at world level:
• Technology (with sub-forecasts for dental products, medical implants, bioprinted tissue, and other uses.
• Products.
Which operations and processes will generate most money from 2014? There you assess outlooks for commercial growth, seeing where you can gain.
Our analysis helps you identify potential in that synthesis for medicine, producing complex geometries and surfaces. There, explore the best revenue-generating prospects.
And that emerging industry holds opportunity in developed and developing countries.
National markets – where will highest revenues and business expansion occur?
Needs for medical devices, diagnostics, and pharmaceuticals expand use of manufacturing technologies using 3D print methods. In our study you examine the technological and commercial scope of those developments, also exploring national opportunities.
Those analyses show you individual revenue forecasts to 2024 for 11 countries:
• United States (US)
• Japan
• Germany, France, UK, Italy, and Spain (EU5)
• Brazil, Russia, India, and China (BRIC Nations).
There you find regions with highest revenues, demand, and sales potentials for that production. Our work explains for those systems and their uses. You find international prospects, then, appraising needs and demands.
So explore how technology for multidimensional printing can benefit its developers, producers, marketers, sellers, and users. Our work shows you, discussing crucial issues.
Events and forces for developing, producing, marketing, and selling
The report explains forces affecting that industry and market from 2014, including these:
• Technologies including selective laser sintering (SLS), direct metal laser sintering (DMLS), electron beam melting (EBM), stereolithography (SLA), and bioprinting
• Orthopaedic and cranio-maxillofacial implants, medical modelling, prototypes, and pharmaceuticals
• Regulatory requirements – abridged pathways and innovation, and challenges with 3D technologies
• Intervertebral discs, bionic organs, bioengineering, skin grafts, implantable cartilage, artificial blood vessels, liver tissue, heart valves, and reconstructive surgery
• Other advances in research and development (R&D) pipelines, inc. efforts improving biocompatibility and enhanced functionality.
There you explore political, economic, social, and technological questions, investigating outlooks for business. Examine what stimulates and restrains that industry and market.
So you discover what the present and future hold for those instruments and their harnessing. See what success is possible from 2014.
Companies and overall 2018 market value – how high can 3D shaping revenues go?
What does the future hold? Our report predicts the world market for those multidimensional printer technologies for health will generate $4043m in 2018. That analysis forecasts high sales growth there from 2014 to 2024. See what’s possible.
There, corporations and specialty providers of that chemical and engineering technology can prosper. You discover how and why.
In particular, then, you explore activities and outlooks of these companies, among others:
• Tissue Regeneration Systems
• Oxford Performance Materials
• Within Technologies
• Tonrud Engineering
• Alphaform
• Arcam
• Stratasys
• 3D Systems
• Organovo.
You find 92 organisations mentioned. Also you read three interviews with authorities in the field. So find what participants do, say, and think, helping you stay ahead.
Ways 3D Printing for Healthcare: R&D, Industry and Market 2014-2024 helps you
Through data such as this, our investigation helps you get recognition for insight:
• Revenues there to 2024 at world level, and for 6 submarkets – assess outlooks for companies, their technology, marketing, and sales
• Forecasts to 2024 for 11 national markets in the Americas, Europe, and Asia – investigate leading countries for revenues and commercial expansion
• Prospects for established competitors, rising firms, and new entrants – investigate portfolios, results, strategies, developmental activities, and successes.
Knowledge found nowhere else, helping your searches, analyses, and plans
Our new report gives independent analysis. There you receive competitive intelligence found only in our work, finding where progress and money lie. Explore possibilities for business.
With that information you’re less likely to fall behind in knowledge or miss opportunity. Being free to choose, you find how you could save time and effort there, helping your decisions and your influence.
Trying our report now lets you discover 3D printing opportunities and predictions
Our new report is for everyone investigating production techniques, equipment, and devices for healthcare. In it you find revenue forecasting to 2024, with opinions and discussions. So avoid missing out – please order now.

【レポートの目次】

1. Executive Summary
1.1 What This Report Covers
1.2 Overview of 3D Printing for Healthcare: Industry and Market 2014-2024
1.3 Chapter Outlines
1.4 Research and Analysis Methods
2. An Introduction to 3D Printing for the Healthcare Industry
2.1 3D Printing
2.1.1 The Original 3D Printing Process
2.1.2 Selective Laser Sintering (SLS)
2.1.3 Direct Metal Laser Sintering (DMLS)
2.1.4 Electron Beam Melting (EBM)
2.1.5 Stereolithography (SLA)
2.2 Bioprinting: The Printing of Living Cells
2.2.1 How 3D Printing With Living Tissue Works
2.2.2 The Near- and Long-Term Applications for 3D Bioprinting
2.2.3 Current Problems with 3D Bioprinting
2.3 The 3D Printing of Pharmaceuticals
2.3.1 3D Printing Technology in Drug Discovery
2.4 Classifying Medical Devices
2.4.1 The US Medical Devices Classification System
2.4.2 The EU Medical Devices Classification System
3. The 3D Printing Market for the Healthcare Industry, 2014-2024
3.1 The 3D Printing Market for Healthcare in 2012: Technology vs. Products
3.2 3D Printed Products in the Healthcare Industry: A Breakdown by Application
3.3 The 3D Printing Market for Healthcare: An Overarching Revenue Forecast 2014-2024
3.4 The Driving and Restraining Factors of the Industry
3.5 3D Printing Technology for Healthcare: Revenue Forecast 2014-2024
3.6 3D Printed Products for Healthcare by Application: Revenue Forecast 2014-2024
3.6.1 Dental Products Dominated the 3D Printed Products Market in 2012, But Will This Continue?
3.6.2 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology
3.6.2.1 The Driving and Restraining Factors Surrounding 3D Printed Medical Implants, 2013
3.6.3 Bioprinted Tissue: Commercial Launch Anticipated in 2014
3.6.4 Other Applications: Medical Modelling, Prototypes and Pharmaceuticals
4. The Leading National Markets for 3D Printing for Healthcare, 2014-2024
4.1 A Geographical Breakdown of 3D Printing Technology Manufacturers for the Healthcare Industry, 2012
4.2 The Leading National Markets for 3D Printing in Healthcare, 2012
4.3 The Leading National Markets: Comparison of Revenue and Market Share, 2018 and 2024
4.4 The Leading National Pharmaceutical Markets for 3D Printing for Healthcare: A Grouped Revenue Forecast, 2014-2024
4.5 The US Will Continue to be the Largest Consumer Throughout the Forecast Period
4.5.1 Pioneering Use of 3D Printed Medical Implants in the US
4.5.2 FDA Regulatory Requirements: Abridged Pathways Foster Innovation
4.6 The EU5 Account for 30% of the Market in 2012, But How Will This Change During the Forecast Period 2014-2024?
4.6.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period
4.6.2 France: Strong Growth but a Decreasing Market Share
4.6.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products
4.6.4 Italian Orthopaedic Device Manufacturers are Prominent Consumers of Arcam’s AM Technology
4.6.5 Spain: the Smallest of the EU5 Will See the Highest Growth
4.7 Japan: Growth Will be Driven by Domestic as well as International Innovation
4.8 China: Domestic Innovation is Keeping Pace with the Western World
4.9 Brazil: A Rapidly Growing Dental Market Presents Opportunities for 3D Printing
4.10 The Indian Market is at an Early Stage
4.11 Will 3D Printing Penetrate the Russian Healthcare Market?
5. 3D Printing for Healthcare: Leading Organisations in the Market
5.1 Leading Organisations in the Industry, 2013-2014
5.2 Organisations in the Medical Implants Sector
5.2.1 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants
5.2.2 Oxford Performance Materials: Selling 3D Printed Implants Since Late 2011
5.2.3 Within Technologies: A Manufacturer of Software for 3D Printing
5.2.3.1 Within Medical: A New Initiative Combining Medical Implant Design Software and a 3D Printing Manufacturing Program
5.2.3.2 The Future of Within Technologies in the Medical Field
5.2.4 C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields
5.2.5 Tonrud Engineering: A Provider of DMSL Since November 2011
5.2.6 Alphaform AG’s Two Business Segments Will Grow Synergistically
5.2.7 3T RPD Ltd: A UK-Based Additive Manufacturing Company
5.2.8 EOS: A Manufacturer of 3D Printers
5.2.9 Arcam AB is Seeing Rapid Growth in 2013
5.2.10 Xilloc Medical: Specialising in Patient-Specific Implants
5.2.11 LayerWise: A Specialist in Metal Additive Manufacturing
5.2.12 3D Systems: High Rates of Growth in the Healthcare Industry
5.2.13 Stratasys: Merged With Objet in December 2012
5.3 Organisations in the 3D Bioprinting Sector
5.3.1 Wake Forest Institute for Regenerative Medicine: Working to Engineer >30 Tissues and Organs Using 3D Printing
5.3.1.1 Timeline for Commercially Available Therapeutic Applications
5.3.1.2 Commercial Applications of the Technology in Drug Development
5.3.2 Organovo: An Early Stage Regenerative Medicine Company
5.4 Organisations in Other Industry Sectors
5.4.1 Aprecia Pharmaceuticals: A Unique Oral Drug Delivery System Produced by 3D Printing Technology
5.4.2 The Cronin Group, University of Glasgow: Working on the 3D Printing of Pharmaceuticals
5.4.3 EnvisionTEC Provides Seven 3D Printing Systems for a Variety of Applications in the Medical and Dental Industries
5.4.4 Materialise NV: 3D Printing Medical Models
6. 3D Printing for the Healthcare Industry: The R&D Pipeline, 2013-2014
6.1 R&D in the Field of Medical Implants
6.1.1 Improving Biocompatibility of 3D Printed Medical Implants with Vitamin B2
6.1.2 3D Printing Intervertebral Discs Could Look Forward to a Share of a $90bn Market
6.1.3 3D Printing of Bionic Organs with Enhanced Functionality
6.2 R&D in the Field of Bioengineering
6.2.1 3D Printing of Skin Grafts: In Hospitals Within 10 Years?
6.2.2 The Production of Implantable Cartilage Using 3D Printing
6.2.3 3D Printing Blood Vessels is a Step Towards the Fabrication of Organs
6.2.3.1 Work at the University of Pennsylvania and MIT
6.2.3.2 Work at Fraunhofer
6.2.4 3D Printing of Functioning Livers at Organovo
6.2.5 3D Printing of Replacement Ears for Reconstructive Surgery
6.2.6 3D Printing to Fabricate Artificial Heart Valves
6.2.7 3D Printing Miniature Spheres with a Lipid Bilayer: Mimicking the Membranes of Living Cells
6.3 R&D in Other Fields
6.3.1 The 3D Printing of Pharmaceuticals: The Potential to Improve Access to Pharmaceuticals in Remote Corners of the World?
7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2013-2014 Onwards
7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare at the End of 2013
7.1.1 The Market is in a High Growth Phase
7.1.2 AM Has a Smaller Resource Footprint
7.1.3 Customised Implants are in High Demand
7.1.4 Producing Complex Shapes and Parts
7.1.5 With High Volume, the Technology is Inefficient
7.1.6 3D Printing Remains Expensive
7.1.7 The Impact of the Adoption of 3D Printing on Jobs in Medical Manufacturing Industries
7.2 Opportunities and Threats Facing the Industry and Market, 2014-2024
7.2.1 Uses of 3D Printing in the Healthcare Industry Expand
7.2.2 The Demand for Personalised Medicine Represents a Lucrative Opportunity
7.2.3 There Exists Much Governmental Investment in the Technologies
7.2.4 Opportunities in Post-Production Finishing
7.2.5 Threats Posed by Questions over Legal Responsibility and Rights
7.2.6 Threats Posed by Alternative Manufacturing Methods
7.3 The Social, Technological, Economic and Political Factors Influencing the 3D Printing Industry for Healthcare, 2014-2024
7.3.1 Social Influences on Market Trends
7.3.2 Technological Influences on Market Trends
7.3.3 Economic Influences on the Market
7.3.4 Political Influences on the Market
8. Research Interviews
8.1 Interview with Andy Middleton, General Manager, EMEA (Europe, Middle East and Africa), Stratasys
8.1.1 On Stratasys’ Offerings for the Healthcare Industry
8.1.2 On the Demand for 3D Printing in Healthcare
8.1.3 On the Future of 3D Printing in the Healthcare Industry
8.2 Interview with Dr Lothar Koch, Head of Biofabrication Group in the Nanotechnology Department, Laser Zentrum Hannover
8.2.1 On Laser-Assisted BioPrinting
8.2.2 On the Uses of 3D Printed Tissue
8.2.3 On 3D Printed Tissue vs. Traditional In Vitro Models
8.2.4 On 3D Printed Tissue for Transplantation
8.2.5 On Research in the Field
8.2.6 On the Timeline for Commercial Availability
8.3 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo
8.3.1 On the Applications for 3D Bioprinting
8.3.2 On the Commercial Prospects of the Technology
8.3.3 On Potential Factors That Could Inhibit Development
8.3.4 On the Timeline for the Use of Bioprinted Tissues in Therapy
9. Conclusions from Our Study
9.1 The 3D Printing Market for the Healthcare Industry: Technology vs. End Products, 2014-2024
9.2 3D Printed Products for the Healthcare Industry by Application: Comparison of Revenue, 2012, 2018 and 2024
9.3 The Leading National Markets for 3D Printing in the Healthcare Industry, 2014-2024
9.4 Trends in the Industry and Market
9.4.1 3D Printing Technology is Already Established in the Field of Dentistry
9.4.2 The Uptake of 3D Printed Orthopaedic Implants is Gathering Pace
9.4.3 An Increasing Focus on Bioprinting
9.4.4 Demand for Technology Corresponds With the Demand for Products



List of Tables
Table 1.1 Currency Exchange Rates
Table 2.1 The US Classification of Medical Devices
Table 2.2 The EU Classification of Medical Devices
Table 3.1 Breakdown of the Market by Technology and Products: Revenue ($m) and Market Share (%), 2012
Table 3.2 3D Printed Products for Healthcare by Application: Revenues ($m) and Market Shares (%), 2012
Table 3.3 3D Printing in the Healthcare Industry by Submarket: Revenue ($m) and Market Share (%) Forecasts, 2013-2024
Table 3.4 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2013-2024
Table 3.5 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%) Forecasts, 2013-2024
Table 3.6 3D Printed Dental Products: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 3.7 3D Printed Medical Implants: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 3.8 Bioprinted Tissue: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 3.9 Other Applications: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.1 Geographical Breakdown of 3D Printing Technology Manufacturers for Healthcare: Revenue ($m) and Market Share (%) by Region, 2012
Table 4.2 Leading National Markets for 3D Printing Technology and 3D Printed Products for Healthcare: Revenue ($m) and Market Share (%), 2012
Table 4.3 The Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Comparisons of Revenue ($m) and Market Share (%), 2018 and 2024
Table 4.4 The Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Revenue Forecasts ($m), 2013-2024
Table 4.5 The US 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.6 The EU5: National Revenue ($m) and Market Share (%) Forecasts, 2013-2024
Table 4.7 The German 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.8 The French 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.9 The UK 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.10 The Italian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.11 The Spanish 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.12 The Japanese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.13 The Chinese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.14 The Brazilian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.15 The Indian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 4.16 The Russian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2013-2024
Table 5.1 Prominent Organisations in the 3D Printing Market for the Healthcare Industry, End of 2013
Table 5.2 Prominent Organisations in the Medical Implant Market, End of 2013
Table 5.3 Medical Implants Designed by Within Technologies' Software, 2013
Table 5.4 Alphaform: Breakdown of Revenue ($m, %) by Business Segment, 2012
Table 5.5 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 1997-2012
Table 5.6 Materials Used by Xilloc Medical, 2013
Table 5.7 The Main Organisations 3D Bioprinting Market, 2013
Table 5.8 Prominent Organisations in Other Industry Sectors Using 3D Printing, 2013
Table 5.9 EnvisionTEC 3D Printing Systems for the Medical and Dental Industries, 2013
Table 6.1 Improving Biocompatibility of 3D Printed Medical Implants: Main Facts, 2013
Table 6.2 3D Printing Intervertebral Discs: Main Facts, 2013
Table 6.3 3D Printing of Bionic Organs: Main Facts, 2013
Table 6.4 3D Printing of Skin Grafts: Main Facts, 2013
Table 6.5 3D Printed Cartilage: Main Facts, 2013
Table 6.6 3D Printing of Blood Vessels: Main Facts, 2013
Table 6.7 3D Printing of Functioning Liver Tissue: Main Facts, 2013
Table 6.8 3D Printing of Replacement Human Ears: Main Facts, 2013
Table 6.9 3D Printing of Heart Valves: Main Facts, 2013
Table 6.10 3D Printing of Material That Mimics Living Cells: Main Facts, 2013
Table 6.11 3D Printing of Pharmaceuticals: Main Facts, 2013
Table 7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare, 2013-2014
Table 7.2 Opportunities and Threats Facing the Industry and Market, 2014-2024
Table 7.3 STEP Analysis: Social, Technological, Economic and Political Forces Influencing the 3D Printing Market for Healthcare, 2014-2024
List of Figures
Figure 3.1 Breakdown of the Market by Technology and Products: Market Share (%), 2012
Figure 3.2 3D Printed Products for Healthcare by Application: Market Share (%), 2012
Figure 3.3 3D Printing in the Healthcare Industry: An Overarching Revenue Forecast ($m), 2013-2024
Figure 3.4 The 3D Printing Market for Healthcare by Submarket: Market Share (%), 2018
Figure 3.5 The 3D Printing Market for Healthcare by Submarket: Market Share (%), 2024
Figure 3.6 Driving and Restraining Factors of 3D Printing for Healthcare, 2014
Figure 3.7 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 3.8 Driving and Restraining Factors of 3D Printing Technology in the Healthcare Industry, 2014
Figure 3.9 3D Printed Products for Healthcare by Application: Revenue Forecast ($m), 2013-2024
Figure 3.10 3D Printed Products by Application: Market Share (%), 2018
Figure 3.11 3D Printed Products by Application: Market Share (%), 2024
Figure 3.12 3D Printed Dental Products: Revenue Forecast ($m), 2013-2024
Figure 3.13 Driving and Restraining Factors of the 3D Printed Dental Product Market, 2014
Figure 3.14 3D Printed Medical Implants: Revenue Forecast ($m), 2013-2024
Figure 3.15 Driving and Restraining Factors of the 3D Printed Medical Implants Market, 2014
Figure 3.16 Bioprinted Tissue: Revenue Forecast ($m), 2013-2024
Figure 3.17 Driving and Restraining Factors of the 3D Bioprinting Market, 2014
Figure 3.18 Other Applications: Revenue Forecast ($m), 2013-2024
Figure 3.19 Driving and Restraining Factors of the Market for Other Applications, 2014
Figure 4.1 Geographical Breakdown of 3D Printing Technology Manufacturers for Healthcare: Market Share by Region (%), 2012
Figure 4.2 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share (%), 2012
Figure 4.3 The Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share (%), 2018
Figure 4.4 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share (%), 2024
Figure 4.5 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Grouped Revenue Forecast ($m), 2013-2024
Figure 4.6 The US 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.7 The EU5 3D Printing Market for Healthcare: Market Share by Country (%), 2012
Figure 4.8 The EU5: National Revenue Forecasts ($m), 2013-2024
Figure 4.9 The German 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.10 The French 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.11 The UK 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.12 The Italian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.13 The Spanish 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.14 The Japanese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.15 The Chinese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.16 The Brazilian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.17 The Indian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 4.18 The Russian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2013-2024
Figure 5.1 Alphaform: Geographical Distribution of Revenue, 1H2013
Figure 5.2 Alphaform: Breakdown of Revenue by Business Segment (%), 2012
Figure 5.3 Arcam: Breakdown of System Sales by Industry, 1997-2012
Figure 5.4 Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 1997-2012
Figure 5.5 3D Systems: Breakdown of Revenue by Industry, 3Q 2013
Figure 6.1 3D Printing Technology for Healthcare: Outline of the R&D Pipeline, 2013
Figure 8.1 Orthodontic Model Produced on a Stratasys Objet30 OrthoDesk 3D Printer
Figure 8.2 VeinViewer® Flex designed Using Stratasys 3D Printed Prototypes
Figure 8.3 VeinViewer® Displaying Blood Beneath the Surface of an Adult Female Hand
Figure 8.4 Jorge Vicente Lopes da Silva, Chief of Tridimensional Technologies Division (DT3D - CTI), Shows 12-year-old Boy's Skull Model Produced on an Objet350 Connex Multi-material 3D Printer
Figure 9.1 3D Printing for the Healthcare Industry: Revenue Forecast ($m) Broken Into Technology and Products, 2013-2024
Figure 9.2 3D Printed Products for the Healthcare Industry by Application: Comparisons of Revenue ($m), 2012, 2018 and 2024
Figure 9.3 The Leading National Markets in the 3D Printing Industry for Healthcare: Comparison of Revenue ($m), 2012, 2018 and 2024


【掲載企業】

3D Systems Corp
3T RPD
5N Plus
Adler Ortho
Alphaform AG
Aprecia Pharmaceuticals
Arcam AB
Asian Manufacturing Association (AMA)
BestinClass SA
Biomet
C&A Tool
Chinese FDA (CFDA)
Clemson University
Compass3D
Conformité Européenne (CE)
Cornell University
Deloitte
DePuy Synthes
Deutsches Herzzentrum Berlin (DHZB)
DiSanto Technology
EnvisionTEC
EOS
Ernst & Young
Expert 3D Solutions
FirstSurface Ltd.
Food and Drug Administration (US FDA)
Fraunhofer Institutes
Hangzhou Dianzi University
Harvard University
Imaginarium
Industry Alliance of China 3D Printing Technology
Invetech
Johns Hopkins University
Knight Cancer Institute
Kyoto University
Laser Zentrum Hannover
LayerWise
Lexmark
Lima Corporate
Maastricht Instruments B.V.
Massachusetts Institute of Technology (MIT)
Materialise NV
Mattel Children's Hospital
MCP HEK Tooling
Medical Modelling
Medimet GMBH
Medtronic
Michael J Fox Foundation
Ministry of Industry and Information Technology
Nakashima Medical
National Additive Manufacturing Innovation Institute (NAMII)
North Carolina State University
Nottingham University Hospitals Trust
Objet
OBL
Office of Science and Engineering Laboratories
Oregon Health and Science University
Organovo
Oxford Performance Materials (OPM)
Peking University 3rd Hospital
Pfizer
Princeton University
Protosys Technologies
Queen's Medical Centre (QMC)
Roche
Royal Perth Hospital, Australia
SIU System
SkinPrint
Smith & Nephew
Sony DADC
State Food and Drug Administration (SFDA)
Stratasys
Stryker
The Cronin Group
The Michael J Fox Foundation
Tissue Regeneration Systems
Tonrud
TU Berlin
UCLA
United Therapeutics
University of Glasgow
University of Michigan
University of North Carolina
University of Oxford
University of Pennsylvania
University of Wisconsin
Wake Forest Institute for Regenerative Medicine (WFIRM)
Walter Reed National Military Medical Center
Weill Cornell Medical College
Within Technologies
Wyss Institute for Biologically Inspired Engineering
Xilloc Medical
Zimmer


★調査レポート[医療用3Dプリンター市場(2014-2024)] ( 3D Printing for Healthcare: R&D, Industry and Market 2014-2024 / Visiongain-4052611) 販売に関する免責事項
[医療用3Dプリンター市場(2014-2024)] ( 3D Printing for Healthcare: R&D, Industry and Market 2014-2024 / Visiongain-4052611) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆